Lucida Medical brings together some of the foremost experts in AI technology and radiology, from leading clinical institutes across Europe.
Our core team is deeply grounded in AI software development and revolutionary applications of medical imaging, both in clinical practice and market development.
Dr Antony Rix
CEO & Co-Founder
PhD Machine learning and AI
Co-founder, Psytechnics (acquired 2011 by Netscout) – patented AI & International standard
Senior Consultant, TTP; CEO & Co-founder, 8power
Expert in software, medical devices & AI development
Professor Evis Sala
Chief Medical Officer & Co-founder
Professor of Oncological Imaging, University of Cambridge & Hon. Consultant Radiologist, Addenbrooke’s Hospital
Former Chief of Body Imaging, Memorial Sloan Kettering Cancer Centre & Professor of Radiology, Weill Cornell Medical College
Board Certified radiologist
Expert in cancer imaging, radiogenomics & AI
Chief Technology Officer
Former Chief Technology Officer at IAG – Image Analysis Group and Chief Giga Officer at Gigalime
Office and Operations Manager
Benita has worked with 5 technology start-ups in Cambridge, UK, where she joined all of them at early stage and has been pivotal in the scale-up process. Three of these have been spun out from the University of Cambridge.
She has vast experience in administrative services, including PA/EA support and HR.
HEAD OF QUALITY AND REGULATORY
Extensive auditing experience including MDSAP and MDR
Formerly Quality Manager at Vision RT
Dr Fabio Geraci
machine Learning engineer
Professional focus includes data analysis and visualisation, machine learning, finite element analysis, and structural analysis.
Previously, a Senior Consultant and FE Specialist for Rolls-Royce UK and a senior FEA Specialist at Red Bull Racing and Red Bull Technology.
Head of finance
Very experienced financial and management accountant, who works with investors, businesses, and charities undergoing transformation phases (Start-up, significant growth, or turn around.)
He is also CFO at Smarter Cardiovascular Outcomes by Research and Education Limited.
Previously he was CFO at a company specialising is prostate cancer diagnosis and treatment
Medical Imaging Entrepreneur
Partner, London Uroradiology
Co-founder of multiple medical imaging and biopsy businesses.
Co-founder, Nuada Medical Group, the pioneer of prostate MRI in private practice 2009 – 2015.
Ran Philips Medical Global Service business 1998 – 2001
Market & business development Advisor
Co-founder, Prostate Matters
Co-founder, Nuada Medical Group 2009 – 2018
Co-founder, Market Equity Ltd a collaboration with Cranfield School of Management 1994 – 2018
Extensive global go-to-market experience with diagnostic imaging companies
Outstanding network of relationships across the prostate diagnosis and treatment market in the UK and Europe
Social Media & Marketing Consultant
Louise is highly experienced at Social Media strategy and execution as well as events promotion and management.
Further, her work at ICIS means she has developed global relationships with many key players in prostate cancer diagnostics.
She is also Social Media & Campaign Manager at Prostate Matters and Marketing Events Manager at the International Cancer Imaging Society (ICIS)
Previously Training and Conference Manager Bowel Cancer UK
Professor Anwar Padhani
Internationally recognised Oncological MRI radiologist and authority on prostate & whole body imaging
Professor of Cancer Imaging, Institute of Cancer Research
Consultant Radiologist & Head of Imaging Research, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London
Co-chair, International PI-RADS (prostate imaging) standards group
Professor Guiseppe Petralia
Director, Precision Imaging & Research Unit, European Oncology Institute (IEO)
Associate Professor, Department of Oncology and Hematology-Oncology, University of Milan
Expert on prostate & whole body MRI for oncology screening, diagnosis, biopsy and treatment management
We collaborate with Cambridge University, we are a partner in the ReIMAGINE prostate imaging trial, are in the process of establishing collaborative partnerships with several UK NHS Trust hospitals to help further develop and validate and test Pi, our AI system for detecting prostate cancer from MRI.